Yongin, South Korea

Eunyoung Lee

This inventor holds 61 USPTO granted patents and 48 published patent applications and 8 EPO patents, primarily in Organic Light-Emitting Devices. Top assignees: Samsung Display Co., Ltd., Samsung Display Co., Ltd., Other. Active years: 2011-2026.

USPTO Granted Patents = 61 

% Patents Active = 91.8

 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • Yongin, KR (2017 - 2019)
  • Daejeon, KR (2011 - 2022)
  • Yongin-si, KR (2018 - 2024)
  • Sejong-si, KR (2023 - 2024)

Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Organometallic Compound
Organic Light-Emitting Device
Electroluminescence
Cyclic Compound
Purification Method
Electronic Apparatus
Ligand
Device Material
Light-Emitting Technology
Organic Electroluminescence
Apparatus
Complex
61 patents (USPTO):Explore Patents

Title: Inventor Eunyoung Lee: Revolutionizing Technology in Yongin-si, KR

Introduction: Eunyoung Lee is a pioneering inventor based in Yongin-si, South Korea, known for her groundbreaking contributions to the field of technology.

Latest Patents: Eunyoung Lee holds several patents in the realm of artificial intelligence and robotics, showcasing her innovative approach to solving complex problems in these domains.

Career Highlights: With a career spanning over two decades, Eunyoung Lee has worked with top research institutions and tech companies, consistently pushing the boundaries of technological advancements.

Collaborations: Throughout her career, Eunyoung Lee has collaborated with leading experts in the industry, fostering a culture of innovation and knowledge-sharing to drive progress in the field.

Conclusion: Eunyoung Lee's dedication to innovation and her relentless pursuit of technological excellence continue to inspire the next generation of inventors and shape the future of technology in Yongin-si, South Korea.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…